Invention Grant
- Patent Title: Amide derivative and use thereof
- Patent Title (中): 酰胺衍生物及其用途
-
Application No.: US13879475Application Date: 2011-10-13
-
Publication No.: US09150555B2Publication Date: 2015-10-06
- Inventor: Hiroyuki Ushio , Maiko Hamada , Masayuki Watanabe , Atsushi Numata , Naoto Fujie , Tooru Takashima , Hiroyuki Furukawa , Junki Ando
- Applicant: Hiroyuki Ushio , Maiko Hamada , Masayuki Watanabe , Atsushi Numata , Naoto Fujie , Tooru Takashima , Hiroyuki Furukawa , Junki Ando
- Applicant Address: JP Osaka-shi
- Assignee: Mitsubishi Tanabe Pharma Corporation
- Current Assignee: Mitsubishi Tanabe Pharma Corporation
- Current Assignee Address: JP Osaka-shi
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2010-231479 20101014
- International Application: PCT/JP2011/073532 WO 20111013
- International Announcement: WO2012/050159 WO 20120419
- Main IPC: A61K31/47
- IPC: A61K31/47 ; C07D211/14 ; C07D405/14 ; C07D401/12 ; C07D401/14 ; C07D405/12 ; C07D417/12 ; C07D495/04

Abstract:
The present invention relates to a novel amide derivative. More specifically, the present invention provides a medicinal agent useful as a prophylactic or therapeutic agent for diseases, which relies on the production of cytokines from T cells, and which comprises an amide derivative or a pharmacologically acceptable salt thereof or a solvate of the derivative or the pharmacologically acceptable salt as an active ingredient. Provided is an amide derivative represented by general formula (I) [wherein each symbol is as defined in the description] or a pharmacologically acceptable salt thereof, or a solvate of the derivative or the pharmacologically acceptable salt.
Public/Granted literature
- US20130211075A1 AMIDE DERIVATIVE AND USE THEREOF Public/Granted day:2013-08-15
Information query